A new study of 6,500 patients, published in the April 11 issue of JAMA, shows that losartan, a primary drug for hypertension, is not linked to a higher all-cause death or cardiovascular death, in comparison with ARB candesartan. Observational studies had indicated that losartan was likely to be...
A study published in the July issue of The American Journal of Medicine, reports that among hypertensive patients with coronary artery disease, chronic self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of adverse events during long-term...